Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data

Reported median overall survival (mOS) in metastatic colorectal cancer (mCRC) patients participating in systemic therapy trials has increased to over 30 months. It is uncertain whether trial results translate to real‐life populations. Moreover, patients prefer presentation of multiple survival scena...

Fuld beskrivelse

Bibliografiske detaljer
Autores principales: Hamers, Patricia A. H., Elferink, Marloes A. G., Stellato, Rebecca K., Punt, Cornelis J. A., May, Anne M., Koopman, Miriam, Vink, Geraldine R.
Format: Online Artículo Texto
Sprog:English
Udgivet: John Wiley & Sons, Inc. 2020
Fag:
Cancer Epidemiology
Online adgang:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754475/
https://www.ncbi.nlm.nih.gov/pubmed/32638384
http://dx.doi.org/10.1002/ijc.33200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754475/
https://www.ncbi.nlm.nih.gov/pubmed/32638384
http://dx.doi.org/10.1002/ijc.33200

Lignende værker